Therapeutic effect of flavonoid rich extract of apricots on high-fat diet induced hyperlipidemia in rabbits

Similar documents
PIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia

Hyperlipidemia. Prepared by : Muhannad Mohammed Supervisor professor : Dr. Ahmed Yahya Dallalbashi

EFFECT OF LYCOPENE IN TOMATO SOUP AND TOMATO JUICE ON THE LIPID PROFILE OF HYPERLIPIDEMIC SUBJECTS

MOLINA HEALTHCARE OF CALIFORNIA

Antihyperlipidemic Drugs

Dyslipidemia Endothelial dysfunction Free radicals Immunologic

STATIN UTILIZATION MANAGEMENT CRITERIA

ANTIHYPERLIPIDEMIA. Darmawan,dr.,M.Kes,Sp.PD

Antihyperlipidemic Drugs

EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT Submitted to UNIVERSITY GRANTS COMMISSION

International Journal of Research and Development in Pharmacy and Life Sciences. Research Article

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

Arteriosclerosis & Atherosclerosis

Topic 11. Coronary Artery Disease

Inspired Functional Ingredients to Innovate and Differentiate Your Brand. Products by Ecovatec Solutions Inc.

BCH 447. Triglyceride Determination in Serum

B. Patient has not reached the percentage reduction goal with statin therapy

Joshua Shepherd PA-C, MMS, MT (ASCP)

Unit IV Problem 3 Biochemistry: Cholesterol Metabolism and Lipoproteins

Joslin Diabetes Center Advances in Diabetes and Thyroid Disease 2013 Consensus and Controversy in Diabetic Dyslipidemia

A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus

International Journal of Pharmacy

Anti Hyperlipidemic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

... CPE/CNE QUIZ... CPE/CNE QUESTIONS

Antihyperlipidemic drugs

Maintain Cholesterol

Comprehensive Treatment for Dyslipidemias. Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium

4/24/15. AHA/ACC 2013 Guideline Key Points

DYSLIPIDEMIA PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

2.5% of all deaths globally each year. 7th leading cause of death by % of people with diabetes live in low and middle income countries

Summary and Conclusions

Management of Post-transplant hyperlipidemia

Medical evidence suggests that

Hypolipidemic effect of Terminalia arjuna (L.) in experimentally induced hypercholesteremic rats

Zuhier Awan, MD, PhD, FRCPC

Lipid Lowering Drugs. Dr. Alia Shatanawi

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY

Introduction: Occurrence of cardiovascular disease.

Pathophysiology of Lipid Disorders

Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona,

Chapter (5) Etiology of Low HDL- Cholesterol

Nature Genetics: doi: /ng.3561

Lipoprotein Particle Profile

Dyslipidemia in the light of Current Guidelines - Do we change our Practice?

Triglyceride determination

Antioxidants in food, drinks and supplements for cardiovascular health

Dyslipidemia. Team Members: Laila Mathkour, Khalid Aleedan, Bayan Al-Mugheerha, Fatima AlTassan

REAGENTS. RANDOX sdldl CHOLESTEROL (sdldl-c) SIZE MATTERS: THE TRUE WEIGHT OF RISK IN LIPID PROFILING

HOW TO CITE THIS ARTICLE:

BIOCHEMISTRY BLOOD - SERUM Result Range Units

Tracking a Killer Molecule

Learning Objectives. Cholesterol and Lipids in Kids: It s a Matter of the Heart. Is Atherosclerosis a Pediatric Disease?

Plasma lipoproteins & atherosclerosis by. Prof.Dr. Maha M. Sallam

Hae Sun Suh, B.Pharm., Ph.D. Jason N. Doctor, Ph.D.

Management of Hyperlipidaemia in General Practice

Natural Approaches to Cholesterol Deregulation

How would you manage Ms. Gold

Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study

The Effects of Moderate Intensity Exercise on Lipoprotein-Lipid Profiles of Haramaya University Community

Lipid Metabolism Prof. Dr. rer physiol. Dr.h.c. Ulrike Beisiegel

Lipoproteins Metabolism Reference: Campbell Biochemistry and Lippincott s Biochemistry

PLASMA LIPOPROTEINS AND LIPIDS DETERMINATION OF PLASMA CHOLESTEROL AND TRIGLICERIDE LEVEL

Chest pain affects 20% to 40% of the general population during their lifetime.

Podcast (Video Recorded Lecture Series): Lipoprotein Metabolism and Lipid Therapy for the USMLE Step One Exam

Effects of Luffa acutangula L. (Cucurbitaceae) Fruit Extract on the Blood. Lipid Profile of Albino Rats

Understanding Cholesterol Holistically

Ezetimibe: a selective inhibitor of cholesterol absorption

Ezetimibe: a selective inhibitor of cholesterol absorption

Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL

EFFECT OF PSYLLIUM HYDROPHILIC MUCILLOID (HUSK) ON PRIMARY HYPERLIPIDEMIC PATIENTS

!!! Aggregate Report Fasting Biometric Screening CLIENT!XXXX. May 2, ,000 participants

Rosuvastatin: An Effective Lipid Lowering Drug against Hypercholesterolemia

Cholesterol metabolism. Function Biosynthesis Transport in the organism Hypercholesterolemia

Lipid profile in Diabetes Mellitus

10/1/2008. Therapy? Disclosure Statement

Effects of Garlic on weight and lipid profile in male albino rats

Dyslipidemia and HIV NORTHWEST AIDS EDUCATION AND TRAINING CENTER

Chapter 18. Diet and Health

Dyslipidemia. (Med-341)

Elements for a Public Summary

Case Discussions: Treatment Strategies for High Risk Populations. Most Common Reasons for Referral to the Baylor Lipid Clinic

HDL-C. J Jpn Coll Angiol, 2008, 48: NIPPON DATA80, MEGA study, JELIS, dyslipidemia, risk assessment chart

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension

Impact of Chronicity on Lipid Profile of Type 2 Diabetics

ARE YOU AT RISK OF A HEART ATTACK OR STROKE? Understand How Controlling Your Cholesterol Reduces Your Risk

CLINICAL IMPORTANCE OF LIPOPROTEINS

JMSCR Vol 05 Issue 05 Page May 2017

1/14/2013 Pediatric Cardiovascular Disease and the Future of our Children Linda Alwine FNP-BC Objectives Identify the prevalence and epidemiology of h

THE CLINICAL BIOCHEMISTRY OF LIPID DISORDERS

Disclosures. Pediatric Dyslipidemia Casey Elkins, DNP, NP C, CLS, FNLA. Learning Objectives. Atherogenesis. Acceptable Values

Fibrate and cardiovascular disease: Evident from meta-analysis. Thongchai Pratipanawatr

International Journal of Chemistry and Pharmaceutical Sciences

Living a Heart Healthy Life. Eleanor Stewart, MSN, RN, AGACNP-BC


HYPERLIPIDEMIA IN THE OLDER POPULATION NICOLE SLATER, PHARMD, BCACP AUBURN UNIVERSITY, HARRISON SCHOOL OF PHARMACY JULY 16, 2016

Coronary heart disease is the leading cause of death in

Prof. John Chapman, MD, PhD, DSc

Lipid/Lipoprotein Structure and Metabolism (Overview)

Dr Anne King dc life dclife.co.uk

Transcription:

Therapeutic effect of flavonoid rich extract of apricots on high-fat diet induced hyperlipidemia in rabbits in rabbits TOOBA LATEEF Assistant Professor Department of Biochemistry Jinnah University for Women Research fellow Department of Biochemistry University of Karachi Presenting in Nutrition Research Symposium 2013

AIM OF THE STUDY To determine the antihyperlipidemic effect of flavonoid rich extract (FREt) of Prunus armeniaca (Apricots) in high-fat diet (HFD) induced hyperlipidemia in rabbits by determining the lipid profile including: total cholesterol (TC) triglycerides (TG) low density lipoprotein (LDL-c) high density lipoprotein (HDL-c) antiatherogenic index (AAI)

Hyperlipidemia, A Risk factor for Coronary Artery Disease! Health organization reports that high blood cholesterol contributes to approximately 56% cases of coronary artery disease worldwide and causes about 4.4 million deaths each year Hyperlipidemia, along with decrease in high-density lipoprotein (HDL-c) is the predictor of coronary artery disease (CAD) and an important risk factor in initiation and progression of atherosclerosis (Makwana et al., 2012) Several factors, such as diet high in saturated fats and cholesterol, age, family history, hypertension and life style play a significant role in the onset of CAD (Dhulasavant et al., 2010)

Therefore, prime consideration in the therapy for hyperlipidemia and arteriosclerosis is to attenuate the elevated blood lipid levels To reduce the risk of CAD researchers are focusing mainly on the treatment of hyperlipidemia (Balamurugan & Shantha, 2010) Treatments include; Diet and life style changes are the first step in treating hyperlipidemia (Lin et al., 2005) The known lipid lowering drugs, such as fibrates, statins and bile acid sequestrants have many side effects Therefore use of natural agents / herbal medicines, due to their minimal side effects and cost effectiveness is increasing day by day all over the world (Sowmya & Ananthi, 2011)

Prunus armeniaca Common name: Apricot Family: Rosaceae Origin: grows over the five continents of the World Rich in minerals, vitamins and a range of bioactive constituents (Jannatezadeh A et al, 2008) Also have hepatoprotective effect (Yurk & Celik, 2011) Beneficial effects on myocardial ischemia-reperfusion injuries (Parlakpinar et al, 2009) Protective effect on intestinal oxidative damages (Vardi et al, 2008) Currently its flavonoid extract was investigated for antihyperlipidemic potential in improving CAD in high-fat diet induced hyperlipidemia in rabbits

METHODOLOGY Preparation of flavonoid rich extract of Apricots; Fruits of P. armeniaca were purchased and grinded to fine powder 10 gms grinded powder, repeatedly extracted with 100 ml 80% aqueous methanol Filtered and evaporated into dryness over water bath Brown residue obtained referred as Flavonoid Rich Extract (FREt) (Bohm & Kocipai- Abyazan method, 1994)

Animals grouping; Control (D.W 1 ml/kg) Rabbits (0.5 1.5 kg) High Fat Diet (HFD) (orally per kg body weight HFD Control (D.W 1 ml/kg) HFD Test HFD Positive Control (Simvastatin 20 mg/kg) FREt (200 mg/kg)

Biochemical Parameters; TC, TG and HDL-c were determined by commercially available kits (Randox, UK) LDL-c and AAI were calculated by formulae; LDL-c (mg/dl) = TC TG/5 HDL-c AAI (%) = [HDL-c / TC HDL-c] x 100 (Vazquez-Freire MJ, et al., 1996) Statistical Analysis; Results expressed as mean ± SD (Standard deviation). Data analyzed by one way ANOVA followed by LSD (least significant difference) test (SPSS, version 17.0). Differences considered significant with p<0.05

Lipid profile (mg/dl) RESULTS Effect of FREt on lipid profile: 250 200 150 * * * TC TG HDL-c LDL-c 100 50 * 0 Control HFD Control HFD Pos Control FREt 200 mg/kg Groups Data: mean ± SD (n=6), * = statistically significant (p<0.05) when compared with HFD control

Antiatherogenic index (%) Effect of FREt on antiatherogenic index (AAI): 200 180 160 140 120 100 80 60 40 20 0 Control HFD Control HFD Pos Control FREt 200 mg/kg Groups * Data: mean ± SD (n=6), * = statistically significant (p<0.05) when compared with HFD control

DISCUSSION According to the result dose of FREt @ 200 showed a significant decrease in serum TC, TG and LDL-c levels and increase in HDL-c level The underlying mechanism of FREt in decreasing cholesterol may be by inhibiting the activity of rate-limiting enzyme of cholesterol metabolism i.e., HMG-CoA reductase (Ahmed, 2011) or by enhancing entero-hepatic circulation of cholesterol (Bahramika et al., 2008) Whereas decrease in TG may be by increasing activity of lipase that hydrolyzes TG under normal conditions or increase excretion of TG via feces (Sukla et al., 2004)

Increase in HDL-c has major role in athero-protective reverse cholesterol transport process involving HDL-c mediated efflux of cholesterol from peripheral tissues to the liver for excretion (Chapman et al., 2010) On the other hand, increase in LDL-c transports cholesterol to peripheral tissues or arteries forming atherosclerotic plug (Qureshi SA et al., 2010) In the present study increase in HDL-c and decrease in LDL-c was observed in test rabbits indicating that apricot FREt has antiatherogenic effect which is confirmed by calculating AAI FREt showed pronounced increase in AAI indicating its cardio-protective effect.

CONCLUSION FREt of P. armeniaca is a potent antihyperlipidemic and antioxidative agent Due to significant effect on lipid profile further research will help in finding most potent dose of P. armeniaca as antiatherogenic agent in humans and its most possible mechanism of action in lowering of blood lipids.

ACKNOWLEDGEMENT Dr. Shamim A. Qureshi (Research Supervisor) Assistant Professor, Department of Biochemistry University of Karachi, Pakistan